Immunotherapy extends survival in mouse model of hard-to-treat breast cancer – Medical Xpress

Immunotherapies for cancertreatments that prime the immune system to attack tumorsare valuable weapons in the anti-cancer arsenal. But some cancers are more difficult to target with this strategy than others. Today, scientists report a new type of immunotherapy that dramatically extends the survival of mice that have triple negative breast tumors, a difficult-to-treat form of cancer.
The researchers will present their results at the American Chemical Society (ACS) Fall 2020 Virtual Meeting &amp…

Click here to view the original article.